Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Innovative Guidewire Advances Coronary Procedures

By HospiMedica International staff writers
Posted on 04 May 2010
A new guidewire equipped with a uniquely designed nickel-titanium (nitinol) sleeve offers significantly improved torque control, compared to conventional spring coil guidewires. More...


The Kinetix Guidewire is intended for use in percutaneous coronary interventions (PCIs), and is designed to deliver enhanced responsiveness and maneuverability in the placement of balloon dilatation catheters or other interventional therapeutic devices during percutaneous trans-luminal cardiac angioplasty (PTCA), percutaneous trans-luminal angioplasty (PTA), or other intravascular procedures. The microcut nitinol sleeve and a nitinol distal core are designed to provide more efficient energy transfer from the physicians hand to the soft distal-tip guide wire tip, resulting in an increased torque transmission and flexibility and an improved turn-for-turn torque response. The Kinetix Guidewire is a product of Boston Scientific (Natick, MA, USA), and is based on the company's Synchro guidewires, used in neurovascular interventions.

"The Kinetix Guidewire provided exceptional torque and flexibility,” said Joseph DeGregorio, M.D., of the Hackensack University Medical Center (NJ, USA), who conducted the first PCI procedure worldwide of the new guidewire. "It's rare to find a workhorse guidewire that combines outstanding deliverability of the wire, support for device deliverability and an excellent safety profile.”

"We're pleased to begin offering this innovative technology that should help physicians simplify coronary angioplasty procedures,” said Hank Kucheman, executive vice president of Boston Scientific, and president of the cardiology, rhythm, and vascular group. "Kinetix reinforces our commitment to providing improved treatment options that promote better patient outcomes.”

Related Links:
Boston Scientific



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
Mammo DR Retrofit Solution
DR Retrofit Mammography
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.